RAPT Therapeutics, Inc. Common Stock (RAPT) Stock Price, Quote & AI Analysis
Live RAPT stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for RAPT Therapeutics, Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for RAPT Therapeutics, Inc. Common Stock (RAPT), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
RAPT Therapeutics, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
RAPT Therapeutics, Inc. Common Stock Overview
Company information
Company Overview
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
RAPT Therapeutics, Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...